Liver Transplant denials in California external review
In the California DMHC record, independent physician reviewers decided 16 published external-review cases involving Liver Transplantand overturned the plan’s denial in 37.5%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Conditions behind Liver Transplant denials
| Category | Decisions | Overturned |
|---|---|---|
| Hepatocellular Carcinoma | 5 | 0% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 13 | 30.8% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 3 | 66.7% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for immediate referral for a liver transplant. Early liver transplant in the setting of decompensated alcoholic liver disease, defined as before six months of abstinence from alcohol, is recommended for carefully selected patients with severe medically refractory alcohol associated liver disease who are considered to be at low risk for alcohol relapse post-transplant (Crabb, et al.). Weinberg and colleagues reported that early liver transplantation has been successfully performed in patients with severe alcohol associated hepatitis and prior liver decompensation. This patient presents with a history of alcohol use disorder, alcohol withdrawal seizures, chronic pancreatitis, and alcohol-associated hepatitis.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for a liver transplant. Metastatic carcinoid or neuroendocrine tumor is a rare cancer that is generally not responsive to cytotoxic chemotherapy. This patient has a metastatic neuroendocrine tumor that is currently restricted to the liver. Since this patient's diagnosis, the patient’s medical care has very closely adhered to National Comprehensive Cancer Network (NCCN) guideline recommendations. However, at this time, the patient has exhausted all standard treatment options and is therefore being considered for transplant. A liver transplant is a reasonable next step for this patient who has tried and failed several standard therapies.
Where the denial was upheld
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for liver transplant. Early liver transplant in the setting of decompensated alcoholic liver disease, defined as before six months of abstinence from alcohol, is recommended for carefully selected patients with severe medically refractory alcohol associated liver disease who are considered to be at low risk for alcohol relapse post-transplant (Crabb, et al.). One study reported by Weinberg and colleagues states that early liver transplantation has been successfully performed in well-selected patients with severe alcohol associated hepatitis and prior liver decompensation. This patient presents with a history of alcohol use disorder.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for liver transplant (CPT 47135). This patient has a metastatic neuroendocrine tumor (NET) with involvement of numerous liver metastases, mass in the tail of the pancreas, ascites and possible lymph node involvement. Although this patient has a well-differentiated tumor, the patient also has several risk factors for recurrence or inferior survival including symptomatic tumor, a primary tumor in the pancreas, and greater than 50% involvement of the liver. The patient may have extrahepatic spread as noted by ascites and lymphadenopathy (Moris, et al.). Liver transplantation has been used in the past for patients with isolated metastases to the liver with mixed results. The proposal in this case is for living donor liver transplantation.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Liver Transplant, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY